Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil versus current practice for dural sealing after skull base surgery
2009-013056-71Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tachosil in cerebrospinal fluid leak (2 arms), sponsored by Takeda. Started Oct 2009; status: completed.
02
Drugs
tachosil
03
Conditions
cerebrospinal fluid leak
Beyond the preview
Go deeper on 2009-013056-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013056-71.